Attached files
| file | filename |
|---|---|
| EX-11 - EXHIBIT 11 - NOVELION THERAPEUTICS INC. | c97388exv11.htm |
| EX-21 - EXHIBIT 21 - NOVELION THERAPEUTICS INC. | c97388exv21.htm |
| EX-32.1 - EXHIBIT 32.1 - NOVELION THERAPEUTICS INC. | c97388exv32w1.htm |
| EX-31.2 - EXHIBIT 31.2 - NOVELION THERAPEUTICS INC. | c97388exv31w2.htm |
| EX-31.1 - EXHIBIT 31.1 - NOVELION THERAPEUTICS INC. | c97388exv31w1.htm |
| EX-32.2 - EXHIBIT 32.2 - NOVELION THERAPEUTICS INC. | c97388exv32w2.htm |
| 10-K - FORM 10-K - NOVELION THERAPEUTICS INC. | c97388e10vk.htm |
EXHIBIT 23
CONSENT OF INDEPENDENT REGISTERED CHARTERED ACCOUNTANTS
We consent to the incorporation by reference in the Registration Statement Nos. 333-2488,
333-12422, 333-100070, 333-120657 and 333-162465 of QLT Inc. on Form S-8 of our reports dated March
10, 2010, relating to the consolidated financial statements and financial statement schedule (which
report expressed an unqualified opinion) of QLT Inc. and the effectiveness of internal control over
financial reporting appearing in the Annual Report on Form 10-K of QLT Inc. for the year ended
December 31, 2009.
/s/ DELOITTE & TOUCHE LLP
Independent Registered Chartered Accountants
Vancouver, Canada
March 10, 2010
March 10, 2010